Flexible Flat-Rate Plans
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
DrugPatentWatch Database Preview
Vincristine sulfate - Generic Drug Details
« Back to Dashboard
This ingredient has forty-one patent family members in sixteen countries.
There are thirteen drug master file entries for vincristine sulfate. Three suppliers are listed for this compound.
Summary for Generic Name: vincristine sulfate
| Tradenames: | 6 |
| Patents: | 3 |
| Applicants: | 9 |
| NDAs: | 13 |
| Drug Master File Entries: see list | 13 |
| Suppliers / Packaging: see list | 3 |
| Drug Prices: | see low prices |
Pharmacology for Ingredient: vincristine sulfate
| Ingredient-type | Vinca Alkaloids |
| Drug Class | Vinca Alkaloid |
Clinical Trials for: vincristine sulfate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | ONCOVIN | vincristine sulfate | INJECTABLE;INJECTION | 014103-001 | Approved Prior to Jan 1, 1982 | DISCN | No | ||||||||||||||||||||||
Talon Therap | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | RX | Yes | 6,723,338 | Mar 31, 2020 | ||||||||||||||||||||
Teva Pharms Usa | VINCRISTINE SULFATE PFS | vincristine sulfate | INJECTABLE;INJECTION | 075493-001 | Sep 1, 1999 | RX | No | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Expired Orange Book Patents for Generic Ingredient: vincristine sulfate
These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Talon Therap | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | 5,543,152 | <disabled> | ||||||||||||||||||||||
Talon Therap | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | 5,814,335 | <disabled> | ||||||||||||||||||||||
Talon Therap | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | 5,741,516 | <disabled> | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Non-Orange Book Patents for Generic Ingredient: vincristine sulfate
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7,452,550 | Liposomal antineoplastic drugs and uses thereof | <disabled in preview> | |||||||||||||||||||||||||||
| 7,244,448 | Liposomal antineoplastic drugs and uses thereof | <disabled in preview> | |||||||||||||||||||||||||||
| 7,244,450 | Compositions and methods for treating lymphoma | <disabled in preview> | |||||||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.
International Patent Family for Ingredient: vincristine sulfate
| Country | Document Number | Estimated Expiration | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Germany | 60115045 | <disabled in preview> | |||||||||||||||||||||||||||
| Denmark | 2266537 | <disabled in preview> | |||||||||||||||||||||||||||
| Austria | 309787 | <disabled in preview> | |||||||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
For more information try a trial or see the database preview and plans and pricing
DrugPatentWatch Resources
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639
